Minghui Pharmaceutical
Minghui Pharmaceutical is a biotech company in Shanghai, China, founded in 2018. It has raised $131.0M across 1 round, most recently a $131.0M Venture Round in August 2025.
- Headquarters
- Shanghai
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- minghuipharma.com
- Total Funding
- $131.0M
- Last Round
- $131.0M Venture RoundAug 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 8 investors for this company. The full record is or through the API.
About
Minghui Pharmaceutical is a Shanghai-based, late-stage clinical biopharmaceutical company developing innovative medicines for oncology and immunology. Its pipeline includes a topical JAK inhibitor under NDA review in China, a subcutaneous IGF-1R antibody in Phase 3 trials for thyroid eye disease, and a PD-1/VEGF bispecific antibody in Phase 2 trials. The company raised $131M in Pre-IPO financing in 2025 led by OrbiMed and Qiming Venture Partners.
Summary
It lists 11–50 employees. It has raised $131.0M in total across 1 round, most recently a $131.0M Venture Round in Aug 2025. Investors include OrbiMed, Qiming VP and TF Capital.
Funding History
Aug 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/minghui-pharmaceutical"><img src="https://indexed.vc/api/badge/company/minghui-pharmaceutical" alt="Minghui Pharmaceutical on Indexed.vc" width="260" height="76" /></a>